Jane Street’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-68,000
Closed -$3.4M 10362
2021
Q3
$3.4M Sell
68,000
-164,300
-71% -$8.96M ﹤0.01% 3417
2021
Q2
$12.9M Buy
232,300
+214,000
+1,169% +$11.4M 0.01% 1450
2021
Q1
$856K Sell
18,300
-1,800
-9% -$87.2K ﹤0.01% 5753
2020
Q4
$875K Buy
20,100
+12,900
+179% +$476K ﹤0.01% 4872
2020
Q3
$264K Buy
+7,200
New +$245K ﹤0.01% 6064

Other funds holding HCAT

Jane Street's HCAT Position: Q1 2026 in Review

Jane Street reduced its Health Catalyst (HCAT) stake by 91% in Q1 2026, selling an estimated $507K and leaving 26,568 shares worth $33.7K. The position accounts for ﹤0.01% of the portfolio, ranked #11083.

Jane Street first reported a position in HCAT in Q1 2021 and has held it in 18 quarters since. The position peaked at $1.68M in Q1 2022. 130 funds tracked by Wall St. Rank hold HCAT as of Q1 2026.

  • Jane Street held 26,568 shares of Health Catalyst worth $33.7K as of Q1 2026.
  • Jane Street sold 269,476 Health Catalyst shares in Q1 2026, an estimated $507K.
  • Health Catalyst made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #11083 holding.
  • Jane Street first reported a position in Health Catalyst in Q1 2021 and has held it in 18 quarters since.
  • Jane Street's Health Catalyst position peaked at $1.68M in Q1 2022.
  • 130 funds tracked by Wall St. Rank held Health Catalyst as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.